Stay updated on Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.

Latest updates to the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page
- Check6 days agoChange DetectedA notice appears announcing NIH website changes and linking to transition updates and FAQs. It says NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check13 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check20 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1; the page remains a 403 error screen.SummaryDifference0.2%

- Check40 days agoChange DetectedIntroduces a 403 Forbidden error display with minimal navigation (such as a Home link), indicating that access to the study record is blocked.SummaryDifference22%

- Check61 days agoChange Detected- The page now displays Revision: v3.6.6, replacing the previous v3.6.5. - This indicates a minor system or page update rather than any change to the study data or content visible to users.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5, indicating a minor update to the study record.SummaryDifference0.0%

Stay in the know with updates to Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.